Download PDF

Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment

This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here

Support open access Recommend

Subscribe